These technologies are speeding COVID-19 vaccines to market
Scientist working with a bioreactor for cell culture. Pharma manufacturing requires digitalization for best results, according to experts at Emerson.

Ben Arriola (BAEM 1983) engineering and a business degree from UMN - Ben is Emerson’s global business development leader for life sciences instrumentation. In this role, his near-term focus is to help Emerson launch a new generation of analytical and measurement single-use instruments. Ben works closely with the automation software and control device business units of Emerson to help the industry realize the vision of inline monitoring and real-time release of biopharmaceutical therapies. He is an active member of ISPE and BioPhorum. 

A combination of digital tools, improved production equipment, and advanced instrumentation helped COVID-19 vaccines to roll out in record time. Read more about it at https://www.pharmaceuticalprocessingworld.com/these-technologies-are-speeding-covid-19-vaccines-to-market/. 

Share